BioSpace News Archive

According to the report, the global hemostasis diagnostics market was valued at US$ 2.3 Bn in 2022 and is anticipated to expand at a CAGR of 8.5% from 2022 to 2030.

The global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2022. It is anticipated to expand at a CAGR of ~3% from 2022 to 2030.

The global vascular access devices market was valued at US$ 6,077.2 Mn in 2022 and is anticipated to expand at a CAGR of 5.8% from 2022 to 2030.

Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically backed supplements, today announced the relaunch of its Activated Charcoal.

Invacare Corporation (“Invacare”) (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by Mobility Management magazine in multiple product categories for outstanding product and technology development in complex rehab.

Forecast to 2030,’ thoroughly examines the Ophthalmoplegia industry to provide essential data & information for the targeted readers.

According to the most recent analysis by Emergen Research, the global market for microbial bioremediation had a value of USD 46,865.2 million in 2021 and is projected to grow at a rate of 11.0 percent during the forecast period.

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.

E-Home Household Service Holdings Limited (NASDAQ: EJH) (the “Company” or “E-Home”), today announced that it has begun a provisional investigation into feasible treatment applications of traditional Chinese medicine for Monkeypox via its recently acquired majority ownership in Zhongrun (Fujian) Pharmaceutical Co., Ltd. (“Zhongrun”), a leading medicine and personal care products operator in China.

Forecast to 2030,’ thoroughly examines the Opioid Overdose industry to provide essential data & information for the targeted readers.